Media coverage
1
Media coverage
Title Vedanta Biosciences Initiates Phase 2 Study for Lead Rationally-Defined Bacterial Consortium Product Candidate, VE303 Media name/outlet India Pharma News Country/Territory India Date 17/12/18 Persons Jeremiah Faith